费城办事处，2021 年 9 月 8 日讯：嘉因生物 Exegenesis Bio 是一家快速发展的全球基因治疗公司，致力于开发针对眼科、中枢神经系统和肝脏疾病的创新基因药物，在此很高兴地宣布其下一阶段的业务扩张，包括计划在未来 12 个月内将规模扩大一倍，并在费城开设业务办事处，在波士顿开设研究业务，并在新加坡开设区域办事处。点击这里读取完整的新闻稿
PHILADELPHIA, PA, Sep 8, 2021 (BUSINESS WIRE) – Exegenesis Bio, a rapidly growing global gene therapy company, developing innovative genetic medicines for eye, CNS and liver-directed diseases is pleased to announce the next phase of its business expansion, including plans to double in size during the next 12 months and opening of business offices in Philadelphia, research operations in Boston and a regional office in Singapore. Read full press release